What do fewer listings, fewer sales, and a lower average price mean for Oro-Medonte heading into September?

August’s year-over-year numbers show fewer active listings and fewer completed sales in Oro-Medonte than one year earlier. A total of 23 homes sold, down 25.8% from 31 in August 2025, while active inventory declined 13.1% from 198 listings to 172.

The average sale price was $948,978, down 13.8% from $1,100,935 last August. Compared with July 2026, however, the average increased slightly from $937,130, while completed sales remained unchanged at 23. In a market with a relatively small number of monthly sales, the mix of homes sold can have a noticeable effect on the average price.

Information provided by Toronto Regional Real Estate Board. August 2026 compared with August 2025. Average sale price can vary based on the type, size, location, and condition of homes sold during the reporting period.

What is happening in the Oro-Medonte real estate market this September?

Oro-Medonte entered September with fewer active listings, fewer completed sales, and a lower average sale price than one year earlier. The year-over-year comparison shows fewer completed sales and a lower average sale price during August.

The month-to-month comparison adds important context. Active listings declined from 190 in July to 172 in August, completed sales remained at 23, and the average sale price increased from $937,130 to $948,978.

How did buyer activity compare with last August?

A total of 23 homes sold in Oro-Medonte during August, compared with 31 one year earlier. This represents a 25.8% decline in completed sales.

The decrease shows that fewer transactions were completed than last August. It does not mean buyers were absent, and it does not describe how every listing performed. Buyer response can vary by location, property type, condition, features, and price point.

What does the inventory change mean for Oro-Medonte buyers and sellers?

Oro-Medonte recorded 172 active listings in August, down 13.1% from 198 in August 2025. Buyers therefore had fewer active listings to consider than they did one year earlier.

The historical graph also shows that inventory remained above the levels recorded during the early months of 2026. Both active listings and completed sales were lower than last August, so these figures alone do not establish whether overall conditions became more favourable to buyers or sellers.

Are Oro-Medonte home prices changing?

Oro-Medonte’s average sale price was $948,978 in August, down 13.8% from $1,100,935 in August 2025. On a month-to-month basis, the average increased slightly from $937,130 in July.

This does not mean every Oro-Medonte home declined in value by 13.8%. A different mix of property types, sizes, locations, conditions, and price ranges can move the monthly average. With 23 completed sales in August, individual higher-priced or lower-priced transactions can have a meaningful effect on the overall figure.

What does this mean if you are buying or selling in September?

For buyers, the lower average price compared with last August is worth examining, but it should not be treated as a direct measure of how much every property has changed in value. Recent comparable sales and the characteristics of each home provide more useful guidance.

For sellers, fewer active listings meant fewer properties were available than last August, but completed sales were also lower. Pricing according to current local conditions, reviewing recent comparable sales, and presenting the property carefully remain important.

Bottom Line

Oro-Medonte’s August numbers show fewer active listings, fewer completed sales, and a lower average sale price than one year earlier. Active inventory declined 13.1%, completed sales fell 25.8%, and the average sale price was 13.8% lower.

Heading into September, buyers and sellers should look beyond the overall averages and focus on recent comparable properties within the relevant location and price range. In a smaller market, the details of what sold during the month can make a substantial difference to the reported results.